Abstract
Children diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for substance abuse. Response inhibition is a hallmark of ADHD, yet the combined effects of ADHD and regular substance use on neural networks associated with response inhibition are unknown. Task-based functional Magnetic Resonance Imaging (fMRI) data from young adults with childhood ADHD with (n = 25) and without (n = 25) cannabis use ≥ monthly in the past year were compared with a local normative comparison group (LNCG) with (n = 11) and without (n = 12) cannabis use. Go/NoGo behavioral and fMRI data were evaluated for main and interaction effects of ADHD diagnosis and cannabis use. ADHD participants made significantly more commission errors on NoGo trials than controls. ADHD participants also had less frontoparietal and frontostriatal activity, independent of cannabis use. No main effects of cannabis use on response inhibition or functional brain activation were observed. An interaction of ADHD diagnosis and cannabis use was found in the right hippocampus and cerebellar vermis, with increased recruitment of these regions in cannabis-using controls during correct response inhibition. ADHD participants had impaired response inhibition combined with less fronto-parietal/striatal activity, regardless of cannabis use history. Cannabis use did not impact behavioral response inhibition. Cannabis use was associated with hippocampal and cerebellar activation, areas rich in cannabinoid receptors, in LNCG but not ADHD participants. This may reflect recruitment of compensatory circuitry in cannabis using controls but not ADHD participants. Future studies targeting hippocampal and cerebellar-dependent function in these groups may provide further insight into how this circuitry is altered by ADHD and cannabis use.
Similar content being viewed by others
Abbreviations
- LNCG:
-
Local Normative Comparison Group
References
Ashtari, M., Avants, B., Cyckowski, L., Cervellione, K. L., Roofeh, D., Cook, P., et al. (2011). Medial temporal structures and memory functions in adolescents with heavy cannabis use. Journal of Psychiatric Research, 45, 1055–1066.
Barkley, R. A., Murphy, K. R., & Fischer, M. (2008). ADHD in adults: What the science says. New York: Guilford.
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar-Poli, P., Crippa, J. A., Nogué, S., et al. (2013). Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS ONE, 8, e55821.
Battisti, R. A., Roodenrys, S., Johnstone, S. J., Pesa, N., Hermens, D. F., & Solowij, N. (2010). Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution. Psychopharmacology, 212, 613–624.
Bellgrove, M. A., Hester, R., & Garavan, H. (2004). The functional neuroanatomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia, 42, 1910–1916.
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2013). Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biological Psychiatry, 75, 470–478.
Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., et al. (2008). Neural basis of Δ-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry, 64, 966–973.
Braver, T. S., Barch, D. M., Gray, J. R., Molfese, D. L., & Snyder, A. (2001). Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cerebral Cortex, 11, 825–836.
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–1977.
Casey, B. J., & Durston, S. (2006). From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder? The American Journal of Psychiatry, 163, 957–960.
Castellanos, F. X., & Proal, E. (2012). Large-scale brain systems in ADHD: beyond the prefrontal–striatal model. Trends in Cognitive Sciences, 16, 17–26.
Clark, L., Roiser, J. P., Robbins, T. W., & Sahakian, B. J. (2009). Disrupted ‘reflection’ impulsivity in cannabis users but not current or former ecstasy users. Journal of Psychopharmacology, 23, 14–22.
Cortese, S., Kelly, C., Chabernaud, C., Proal, E., Di Martino, A., Milham, M. P., & Castellanos, X. F. (2012). Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. The American Journal of Psychiatry, 169, 1038–1055.
Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2012). Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. NeuroImage, 59, 3845–3851.
Criaud, M., & Boulinguez, P. (2013). Have we been asking the right questions when assessing response inhibition in go/no-go tasks with fMRI? A meta-analysis and critical review. Neuroscience and Biobehavioral Reviews, 37, 11–23.
Dickstein, S. G., Bannon, K., Castellanos, X. F., & Milham, M. P. (2006). The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. Journal of Child Psychology and Psychiatry, 47, 1051–1062.
Dougherty, D. M., Mathias, C. W., Dawes, M. A., Furr, R. M., Charles, N. E., Ligouri, A., et al. (2012). Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology, 226, 307–319.
Durston, S., Tottenham, N. T., Thomas, K. M., Davidson, M. C., Eigsti, I. M., Yang, Y., et al. (2003). Differential patterns of striatal activation in young children with and without ADHD. Biological Psychiatry, 53, 871–878.
Glover, G. H., Mueller, B. A., Turner, J. A., van Erp, T. G. M., Liu, T. T., Greve, D. N., et al. (2012). Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. Journal of Magnetic Resonance Imaging, 36, 39–54.
Gonzalez, R., Schuster, R. M., Mermelstein, R. J., Vassileva, J., Martin, E. M., & Diviak, K. R. (2012). Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. Journal of Clinical and Experimental Neuropsychology, 34, 962–976.
Hart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder. JAMA Psychiatry, 70, 185–198.
Hester, R., Nestor, L., & Garavan, H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology, 34, 2450–2458.
Iacono, W. G., Malone, S. M., & McGue, M. (2008). Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annual Review of Clinical Psychology, 4, 325–348.
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012). FSL. NeuroImage, 62, 782–790.
Jiang, W., Zhang, Y., Xiao, L., van Cleemput, J., Ji, S. P., Bai, G., & Zhang, X. (2005). Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. Journal of Clinical Investigation, 115, 3104–3116.
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clinical Psychology Review, 31, 328–341.
Leth-Steensen, C., Elbaz, Z. K., & Douglas, V. I. (2000). Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psychologica, 104, 167–190.
Marije Boonstra, A., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2005). Executive functioning in adult ADHD: a meta-analytic review. Psychological Medicine, 35, 1097–1108.
Martín-Santos, R., Fagundo, A. B., Crippa, J. A., Atakan, Z., Bhattacharyya, S., Allen, P., et al. (2009). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine, 40, 383–398.
Matochik, J. A., Eldreth, D. A., Cadet, J. L., & Bolla, K. I. (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence, 77, 23–30.
McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology, 28, 1356–1365.
McNamee, R. L., Dunfee, K. L., Luna, B., Clark, D. B., Eddy, W. F., & Ralph, E. T. (2008). Brain activation, response inhibition, and increased risk for substance use disorder. Alcoholism: Clinical and Experimental Research, 32, 405–413.
Molina, B. S. G., & Pelham, W. E. (2014). Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research. Annual Review of Clinical Psychology, 10, 607–639.
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., et al. (2009). The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 484–500.
Moreno, M., Estevez, A. F., Zaldivar, F., Montes, J. M. G., Gutiérrez-Ferre, V. E., Esteban, L., et al. (2012). Impulsivity differences in recreational cannabis users and binge drinkers in a university population. Drug and Alcohol Dependence, 124, 355–362.
Nestor, L., Roberts, G., Garavan, H., & Hester, R. (2008). Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. NeuroImage, 40, 1328–1339.
Peterson, B. S., Potenza, M. N., Wang, Z., Zhu, H., Martin, A., Marsh, R., et al. (2009). An fMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. American Journal of Psychiatry, 166, 1286–1294.
Piechatzek, M., Indlekofer, F., Daamen, M., Glasmacher, C., Lieb, R., Pfister, F., et al. (2009). Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Human Psychopharmacology: Clinical and Experimental, 24, 650–665.
Roberts, G. M. P., & Garavan, H. (2010). Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. NeuroImage, 52, 429–435.
Rubia, K., Smith, A. B., Taylor, E., & Brammer, M. (2007). Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Human Brain Mapping, 28, 1163–1177.
Rubia, K., Lena, L., Ecker, C., Halari, R., Giampietro, V., Simmons, A., et al. (2013). Effects of age and gender on neural networks of motor response inhibition: from adolescence to mid-adulthood. NeuroImage, 83, 690–703.
Shaw, P., Exckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., & Greenstein, D. (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. PNAS, 49, 19649–19654.
Slaats-Willemse, D., Swaab-Barneveld, H., de Sonneville, L., van der Meulen, E., & Buitelaar, J. (2003). Deficient response inhibition as a cognitive endophenotype of ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1242–1248.
Smith, A. M., Zunini, R. A. L., Anderson, C. D., Longo, C. A., Cameron, I., Hogan, M. J., & Fried, P. A. (2011). Impact of marijuana on response inhibition: an fMRI study in young adults. Journal of Behavioral and Brain Science, 1, 124–133.
Somerville, L. H., Hare, T., & Casey, B. J. (2011). Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents. Journal of Cognitive Neuroscience, 23, 2123–2134.
Tamm, L., Epstein, J. N., Lisdahl, K. M., Molina, B., Tapert, S., Hinshaw, S. P., et al. (2013). Impact of ADHD and cannabis use on executive functioning in young adults. Drug and Alcohol Dependence, 133, 607–614.
Tapert, S. F., Schweinsburg, A. D., Drummond, S. P. A., Paulus, M. P., Brown, S. A., Yang, T. T., & Frank, L. R. (2007). Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology, 194, 173–183.
Terzian, A. L., Drago, F., Wotjak, C. T., & Micale, V. (2011). The dopamine and cannabinoid interaction in the modulation of emotions and cognition: assessing the role of cannabinoid CB1 receptor in neurons expressing dopamine D1 receptors. Frontiers in Behavioral Neuroscience, 49, 1–10. doi:10.3389/fnbeh.2011.00049/abstract.
Tottenham, N., Tanaka, J. W., Leon, A. C., McCarry, T., Nurse, M., Hare, T., et al. (2009). The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Research, 168, 242–249.
Valjent, E., Mitchell, J. M., Besson, M. J., Caboche, J., & Maldonado, R. (2002). Behavioural and biochemical evidence for interactions between h9-tetrahydrocannabinol and nicotine. British Journal of Pharmacology, 135, 564–578.
van Holst, R. J., & Schilt, T. (2011). Drug-related decrease in neuropsychological functions of abstinent drug users. Current Drug Abuse Reviews, 4, 42–56.
Worsley, K. J., Liao, C. H., Petre, V., Duncan, G. H., Morales, F., & Evans, A. C. (2002). A general statistical analysis for fMRI data. NeuroImage, 15, 1–15.
Yeo, B. T. T., Krienen, F. M., Sepulcre, J., Sabuncu, M. R., Lashkari, D., Hollinshead, M., et al. (2011). The organization of the human cerebral cortex estimated by intrinsic functional connectivity. Journal of Neurophysiology, 106, 1125–1165.
Acknowledgments
This project was funded by the National Institute on Drug Abuse (NIDA) Multimodal Treatment Study of Children with ADHD (MTA) Neuroimaging Study (NIDA Contract #: HHSN271200800009C).
We thank the participants of this study and the numerous staff involved with the coordination of visits, particularly Shichun Ling for her administrative support in the preparation of this manuscript.
Portions of this work were presented as a poster at the International Society for Magnetic Resonance Imaging in Medicine, Salt Lake City, USA 2013.
1The Multimodal Treatment Study of Children with ADHD (MTA) was a National Institute of Mental Health (NIMH) cooperative agreement randomized clinical trial, continued under an NIMH contract as a follow-up study and finally under a National Institute on Drug Abuse (NIDA) contract. Collaborators from NIMH: L. Eugene Arnold, M.D., M.Ed. (currently at Ohio State University). Principal investigators and co-investigators from the sites are: University of California, Berkeley/San Francisco: Stephen P. Hinshaw, Ph.D. (Berkeley), Glen R. Elliott, Ph.D., M.D. (San Francisco); Duke University: Karen C. Wells, Ph.D., Jeffery N. Epstein, Ph.D. (currently at Cincinnati Children’s Hospital Medical Center), Desiree W. Murray, Ph.D.; University of California, Irvine: James Swanson, Ph.D., Timothy Wigal, Ph.D.; New York University: Howard B. Abikoff, Ph.D.; New York State Psychiatric Institute/Columbia University/Mount Sinai Medical Center: Laurence L. Greenhill, M.D. (Columbia). University of Pittsburgh: Brooke Molina, Ph.D., Additional investigators for Neuroimaging Study: Leanne Tamm, Ph.D., PI (Cincinnati Children’s Hospital Medical Center), James Bjork, Ph.D. (Division of Clinical Neuroscience and Behavioral Research, NIDA), Daniel Mathalon, M.D., Ph.D. (UC San Francisco), Allen Song, Ph.D. (Duke), Bradley Peterson, M.D. (Columbia), Steven G. Potkin, M.D., Theo G.M. van Erp & Claudia Buss, Ph.D. (UC Irvine), Katerina Velanova, Ph.D. (Pittsburgh), Neuroimaging Consultants: Susan Tapert, Ph.D. & Joshua Kuperman, Ph.D. (UC San Diego), BJ Casey, Ph.D. (Sackler Institute, Weill Cornell Medical College), Leah Somerville, Ph.D.,(Department of Psychology, Harvard University), Krista Lisdahl, Ph.D. (University of Wisconsin-Milwaukee). Neuroimaging Analysis and Interpretation: Terry Jernigan, Ph.D. & Anders Dale, Ph.D. (UC San Diego), F. Xavier Castellanos, M.D. & Clare Kelly, Ph.D. (New York University).
Financial disclosures
Dr. Arnold has received research funding from CureMark, Fore- str, Lilly, and Shire, advisory board honoraria from Biomarin, Novartis, Noven, Roche, Seaside Therapeutics, and Shire, consulting fees from Tris Pharma, and travel support from Noven.
Dr. Swanson has received research support from Alza, Richwood, Shire, Celgene, Novartis, Celltech, Gliatech, Cephalon, Watson, CIBA, Janssen, and McNeil; has been on the advisory board for Alza, Rich- wood, Shire, Celgene, Novartis, Celltech, UCB, Gliatech, Cephalon, McNeil, and Lilly; has been on speaker’s bureau for Alza, Shire, Novartis, Celltech, UCB, Cephalon, CIBA, Janssen, and McNeil; and has consulted to Alza, Richwood, Shire, Celgene, Novartis, Celltech, UCB, Gliatech, Cephalon, Watson, CIBA, Janssen, McNeil, and Lilly.
Dr. van Erp has been a consultant for Roche Pharmaceuticals.
Dr. Mathalon is a consultant for Bristol-Myers Squibb and has consulted for Roche Pharmaceuticals.
Dr. Potkin’s work has been funded by the NIH. Dr. Potkin has received grant support, funding, honoraria, or has been a paid consultant to the following companies that conducted scientific or medical research and/or marketed medications related to psychiatric and neurodegenerative disorders: Alkermes, Eli Lilly, FORUM, Genentech, Janssen, Lundbeck, Merck, Novartis, Otsuka, Roche, Sunovion, Takeda, Toyama, and Vanda.
The remaining authors report no biomedical financial interests or potential conflicts of interest.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, and the applicable revisions at the time of the investigation. Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Consortia
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplemental Figure 1
(DOC 123 kb)
Rights and permissions
About this article
Cite this article
Rasmussen, J., Casey, B.J., van Erp, T.G.M. et al. ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging and Behavior 10, 761–771 (2016). https://doi.org/10.1007/s11682-015-9438-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-015-9438-9